Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,480.00
(
-1.02%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
2.39%
)
Bitcoin
70,678.01
(
1.12%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

floblu14

Send PM Follow Ignore
Followers 24
Posts 3957
Boards Moderated 0
Alias Born 07/20/2006

floblu14

Re: None

Friday, 09/28/2007 8:50:28 AM

Friday, September 28, 2007 8:50:28 AM

Post# of 19309
>Gelineau said SAFC also is negotiating with Framingham, Mass.-based GTC Biotherapeutics Inc., a biotech company that developed ATryn, an anti-clotting agent produced in the milk of genetically modified goats. ATryn has been approved for use by the European Commission and is in late-stage human clinical trials in the United States.<

http://www.stltoday.com/stltoday/business/stories.nsf/manufacturingtechnology/story/7E5FBCCD56DBF22E...
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today